Double Cross OTC products the operation of.docVIP

 PAGE \* MERGEFORMAT 14 ‘Double Cross’ OTC products the operation of In recent years, with the prescription drug marketing, environmental degradation, as well as the huge potential of China’s OTC market, the temptation, prompting some companies in the prescription drug manufacturing enterprises, and gradually transition to the OTC. OTC market has led to a number of promising products, while OTC and prescription drugs have achieved the dual status and they pedal hospitals and pharmacies two markets, two-way Nuggets. This is the so-called ‘double-cross’ products. In fact, with respect to prescription drug-based pharmaceutical companies to enter the OTC market opening has an unparalleled advantage. Of non-prescription drugs management approach provides new drugs in the market for two years before they can apply for evaluation of non-prescription drugs. This has determined that non-prescription drugs to go through the process of prescription drug promotion. And some prescription drugs in the hospital after years of promotion, it’s safety and efficacy of a large number of clinical data to be fully proved that the product of the medical knowledge, thereby reducing the risk of non-prescription drug market, but also for entry into the OTC market, providing the necessary financial support. However, OTC has just been involved in the operation of the ‘double-cross’ products, arising from the restructuring in the face of joy at the same time, but also how to deal with the key to the operation of good products? In addition, desire to enter the ‘double cross’ products in the field of business, how does it work? In this, the author of ‘Double Cross’ OTC products, the operation of a study done for the industry reference. Prudent planning before action, transforming the preparatory work before 1, selective advantage to the OTC species change. To prescription drug-based pharmaceutical companies should be based on their own advantages, combined with its own characteristics